Baidu
map
CURR MOL MED 润色咨询

CURRENT MOLECULAR MEDICINE

出版年份：2001 年文章数：1578 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：2.1% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2143876, encodeId=bbe321438e667, content=审稿速度:12.0 | 投稿命中率:25.0<br>经验分享：7个多月后给出拒稿，基因家族在胃癌中的生信研究<br>sci分在不断往下走，真心不建议 试投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Tue Jun 20 13:36:38 CST 2023, time=2023-06-20, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1226110, encodeId=017f122611088, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享：迟迟不见状态改变啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83178200737, createdName=ms9000000393798485, createdTime=Mon Jun 13 08:59:36 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087225, encodeId=2d2a108e225fe, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087226, encodeId=5f43108e226b2, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575205, encodeId=bab65e520509, content=请问最后多久给消息了呀？是好消息还是坏消息？<span class="quote">lixindentist 2018-04-01 发表::<br>已经投稿1年多了，还是没有动静，这是怎么回事啊</span><span class="quote">lixindentist 2018-04-01 15:13:00 发表:<br>已经投稿1年多了，还是没有动静，这是怎么回事啊</span>, beContent=lixindentist 2018-04-01 发表:: 已经投稿1年多了，还是没有动静，这是怎么回事啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78212477466, createdName=才开始, createdTime=Thu Aug 22 00:00:00 CST 2019, time=2019-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554412, encodeId=cc305544124b, content=已经投稿1年多了，还是没有动静，这是怎么回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=afc01712357, createdName=lixindentist, createdTime=Sun Apr 01 15:13:00 CST 2018, time=2018-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539888, encodeId=a2bf5398883a, content=跌跌不休，再往下，会不会破2。一年就跌下不少，哪怕0.1分，也应该值得珍惜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13801938855, createdTime=Tue Jul 18 18:36:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537766, encodeId=5a1a53e766e4, content=一审到接收，1年半, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=367, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e49d1622204, createdName=xiaxianyue1912, createdTime=Wed Jun 14 07:54:00 CST 2017, time=2017-06-14, status=1, ipAttribution=)]
    2023-06-20 ms2000000713462597 来自江西省

    审稿速度:12.0 | 投稿命中率:25.0
    经验分享：7个多月后给出拒稿，基因家族在胃癌中的生信研究
    sci分在不断往下走，真心不建议 试投。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2143876, encodeId=bbe321438e667, content=审稿速度:12.0 | 投稿命中率:25.0<br>经验分享：7个多月后给出拒稿，基因家族在胃癌中的生信研究<br>sci分在不断往下走，真心不建议 试投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Tue Jun 20 13:36:38 CST 2023, time=2023-06-20, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1226110, encodeId=017f122611088, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享：迟迟不见状态改变啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83178200737, createdName=ms9000000393798485, createdTime=Mon Jun 13 08:59:36 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087225, encodeId=2d2a108e225fe, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087226, encodeId=5f43108e226b2, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575205, encodeId=bab65e520509, content=请问最后多久给消息了呀？是好消息还是坏消息？<span class="quote">lixindentist 2018-04-01 发表::<br>已经投稿1年多了，还是没有动静，这是怎么回事啊</span><span class="quote">lixindentist 2018-04-01 15:13:00 发表:<br>已经投稿1年多了，还是没有动静，这是怎么回事啊</span>, beContent=lixindentist 2018-04-01 发表:: 已经投稿1年多了，还是没有动静，这是怎么回事啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78212477466, createdName=才开始, createdTime=Thu Aug 22 00:00:00 CST 2019, time=2019-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554412, encodeId=cc305544124b, content=已经投稿1年多了，还是没有动静，这是怎么回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=afc01712357, createdName=lixindentist, createdTime=Sun Apr 01 15:13:00 CST 2018, time=2018-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539888, encodeId=a2bf5398883a, content=跌跌不休，再往下，会不会破2。一年就跌下不少，哪怕0.1分，也应该值得珍惜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13801938855, createdTime=Tue Jul 18 18:36:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537766, encodeId=5a1a53e766e4, content=一审到接收，1年半, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=367, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e49d1622204, createdName=xiaxianyue1912, createdTime=Wed Jun 14 07:54:00 CST 2017, time=2017-06-14, status=1, ipAttribution=)]
    2022-06-13 ms9000000393798485

    审稿速度:12.0 | 投稿命中率:50.0
    经验分享：迟迟不见状态改变啊

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2143876, encodeId=bbe321438e667, content=审稿速度:12.0 | 投稿命中率:25.0<br>经验分享：7个多月后给出拒稿，基因家族在胃癌中的生信研究<br>sci分在不断往下走，真心不建议 试投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Tue Jun 20 13:36:38 CST 2023, time=2023-06-20, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1226110, encodeId=017f122611088, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享：迟迟不见状态改变啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83178200737, createdName=ms9000000393798485, createdTime=Mon Jun 13 08:59:36 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087225, encodeId=2d2a108e225fe, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087226, encodeId=5f43108e226b2, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575205, encodeId=bab65e520509, content=请问最后多久给消息了呀？是好消息还是坏消息？<span class="quote">lixindentist 2018-04-01 发表::<br>已经投稿1年多了，还是没有动静，这是怎么回事啊</span><span class="quote">lixindentist 2018-04-01 15:13:00 发表:<br>已经投稿1年多了，还是没有动静，这是怎么回事啊</span>, beContent=lixindentist 2018-04-01 发表:: 已经投稿1年多了，还是没有动静，这是怎么回事啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78212477466, createdName=才开始, createdTime=Thu Aug 22 00:00:00 CST 2019, time=2019-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554412, encodeId=cc305544124b, content=已经投稿1年多了，还是没有动静，这是怎么回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=afc01712357, createdName=lixindentist, createdTime=Sun Apr 01 15:13:00 CST 2018, time=2018-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539888, encodeId=a2bf5398883a, content=跌跌不休，再往下，会不会破2。一年就跌下不少，哪怕0.1分，也应该值得珍惜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13801938855, createdTime=Tue Jul 18 18:36:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537766, encodeId=5a1a53e766e4, content=一审到接收，1年半, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=367, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e49d1622204, createdName=xiaxianyue1912, createdTime=Wed Jun 14 07:54:00 CST 2017, time=2017-06-14, status=1, ipAttribution=)]
    2021-12-28 桑晒麦拉

    如何判断两种药物之间是协同作用还是相加作用？

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2143876, encodeId=bbe321438e667, content=审稿速度:12.0 | 投稿命中率:25.0<br>经验分享：7个多月后给出拒稿，基因家族在胃癌中的生信研究<br>sci分在不断往下走，真心不建议 试投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Tue Jun 20 13:36:38 CST 2023, time=2023-06-20, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1226110, encodeId=017f122611088, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享：迟迟不见状态改变啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83178200737, createdName=ms9000000393798485, createdTime=Mon Jun 13 08:59:36 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087225, encodeId=2d2a108e225fe, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087226, encodeId=5f43108e226b2, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575205, encodeId=bab65e520509, content=请问最后多久给消息了呀？是好消息还是坏消息？<span class="quote">lixindentist 2018-04-01 发表::<br>已经投稿1年多了，还是没有动静，这是怎么回事啊</span><span class="quote">lixindentist 2018-04-01 15:13:00 发表:<br>已经投稿1年多了，还是没有动静，这是怎么回事啊</span>, beContent=lixindentist 2018-04-01 发表:: 已经投稿1年多了，还是没有动静，这是怎么回事啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78212477466, createdName=才开始, createdTime=Thu Aug 22 00:00:00 CST 2019, time=2019-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554412, encodeId=cc305544124b, content=已经投稿1年多了，还是没有动静，这是怎么回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=afc01712357, createdName=lixindentist, createdTime=Sun Apr 01 15:13:00 CST 2018, time=2018-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539888, encodeId=a2bf5398883a, content=跌跌不休，再往下，会不会破2。一年就跌下不少，哪怕0.1分，也应该值得珍惜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13801938855, createdTime=Tue Jul 18 18:36:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537766, encodeId=5a1a53e766e4, content=一审到接收，1年半, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=367, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e49d1622204, createdName=xiaxianyue1912, createdTime=Wed Jun 14 07:54:00 CST 2017, time=2017-06-14, status=1, ipAttribution=)]
    2021-12-27 乌云背后的幸福线

    如果文章发表了未提供ORCIDID如何添加？

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2143876, encodeId=bbe321438e667, content=审稿速度:12.0 | 投稿命中率:25.0<br>经验分享：7个多月后给出拒稿，基因家族在胃癌中的生信研究<br>sci分在不断往下走，真心不建议 试投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Tue Jun 20 13:36:38 CST 2023, time=2023-06-20, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1226110, encodeId=017f122611088, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享：迟迟不见状态改变啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83178200737, createdName=ms9000000393798485, createdTime=Mon Jun 13 08:59:36 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087225, encodeId=2d2a108e225fe, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087226, encodeId=5f43108e226b2, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575205, encodeId=bab65e520509, content=请问最后多久给消息了呀？是好消息还是坏消息？<span class="quote">lixindentist 2018-04-01 发表::<br>已经投稿1年多了，还是没有动静，这是怎么回事啊</span><span class="quote">lixindentist 2018-04-01 15:13:00 发表:<br>已经投稿1年多了，还是没有动静，这是怎么回事啊</span>, beContent=lixindentist 2018-04-01 发表:: 已经投稿1年多了，还是没有动静，这是怎么回事啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78212477466, createdName=才开始, createdTime=Thu Aug 22 00:00:00 CST 2019, time=2019-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554412, encodeId=cc305544124b, content=已经投稿1年多了，还是没有动静，这是怎么回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=afc01712357, createdName=lixindentist, createdTime=Sun Apr 01 15:13:00 CST 2018, time=2018-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539888, encodeId=a2bf5398883a, content=跌跌不休，再往下，会不会破2。一年就跌下不少，哪怕0.1分，也应该值得珍惜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13801938855, createdTime=Tue Jul 18 18:36:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537766, encodeId=5a1a53e766e4, content=一审到接收，1年半, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=367, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e49d1622204, createdName=xiaxianyue1912, createdTime=Wed Jun 14 07:54:00 CST 2017, time=2017-06-14, status=1, ipAttribution=)]
    2019-08-22 才开始

    请问最后多久给消息了呀？是好消息还是坏消息？lixindentist 2018-04-01 发表::
    已经投稿1年多了，还是没有动静，这是怎么回事啊    lixindentist 2018-04-01 15:13:00 发表:
    已经投稿1年多了，还是没有动静，这是怎么回事啊

    lixindentist 2018-04-01 发表:: 已经投稿1年多了，还是没有动静，这是怎么回事啊

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2143876, encodeId=bbe321438e667, content=审稿速度:12.0 | 投稿命中率:25.0<br>经验分享：7个多月后给出拒稿，基因家族在胃癌中的生信研究<br>sci分在不断往下走，真心不建议 试投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Tue Jun 20 13:36:38 CST 2023, time=2023-06-20, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1226110, encodeId=017f122611088, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享：迟迟不见状态改变啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83178200737, createdName=ms9000000393798485, createdTime=Mon Jun 13 08:59:36 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087225, encodeId=2d2a108e225fe, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087226, encodeId=5f43108e226b2, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575205, encodeId=bab65e520509, content=请问最后多久给消息了呀？是好消息还是坏消息？<span class="quote">lixindentist 2018-04-01 发表::<br>已经投稿1年多了，还是没有动静，这是怎么回事啊</span><span class="quote">lixindentist 2018-04-01 15:13:00 发表:<br>已经投稿1年多了，还是没有动静，这是怎么回事啊</span>, beContent=lixindentist 2018-04-01 发表:: 已经投稿1年多了，还是没有动静，这是怎么回事啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78212477466, createdName=才开始, createdTime=Thu Aug 22 00:00:00 CST 2019, time=2019-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554412, encodeId=cc305544124b, content=已经投稿1年多了，还是没有动静，这是怎么回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=afc01712357, createdName=lixindentist, createdTime=Sun Apr 01 15:13:00 CST 2018, time=2018-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539888, encodeId=a2bf5398883a, content=跌跌不休，再往下，会不会破2。一年就跌下不少，哪怕0.1分，也应该值得珍惜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13801938855, createdTime=Tue Jul 18 18:36:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537766, encodeId=5a1a53e766e4, content=一审到接收，1年半, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=367, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e49d1622204, createdName=xiaxianyue1912, createdTime=Wed Jun 14 07:54:00 CST 2017, time=2017-06-14, status=1, ipAttribution=)]
    2018-04-01 lixindentist

    已经投稿1年多了，还是没有动静，这是怎么回事啊

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2143876, encodeId=bbe321438e667, content=审稿速度:12.0 | 投稿命中率:25.0<br>经验分享：7个多月后给出拒稿，基因家族在胃癌中的生信研究<br>sci分在不断往下走，真心不建议 试投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Tue Jun 20 13:36:38 CST 2023, time=2023-06-20, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1226110, encodeId=017f122611088, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享：迟迟不见状态改变啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83178200737, createdName=ms9000000393798485, createdTime=Mon Jun 13 08:59:36 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087225, encodeId=2d2a108e225fe, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087226, encodeId=5f43108e226b2, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575205, encodeId=bab65e520509, content=请问最后多久给消息了呀？是好消息还是坏消息？<span class="quote">lixindentist 2018-04-01 发表::<br>已经投稿1年多了，还是没有动静，这是怎么回事啊</span><span class="quote">lixindentist 2018-04-01 15:13:00 发表:<br>已经投稿1年多了，还是没有动静，这是怎么回事啊</span>, beContent=lixindentist 2018-04-01 发表:: 已经投稿1年多了，还是没有动静，这是怎么回事啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78212477466, createdName=才开始, createdTime=Thu Aug 22 00:00:00 CST 2019, time=2019-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554412, encodeId=cc305544124b, content=已经投稿1年多了，还是没有动静，这是怎么回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=afc01712357, createdName=lixindentist, createdTime=Sun Apr 01 15:13:00 CST 2018, time=2018-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539888, encodeId=a2bf5398883a, content=跌跌不休，再往下，会不会破2。一年就跌下不少，哪怕0.1分，也应该值得珍惜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13801938855, createdTime=Tue Jul 18 18:36:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537766, encodeId=5a1a53e766e4, content=一审到接收，1年半, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=367, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e49d1622204, createdName=xiaxianyue1912, createdTime=Wed Jun 14 07:54:00 CST 2017, time=2017-06-14, status=1, ipAttribution=)]
    2017-07-18 13801938855

    跌跌不休，再往下，会不会破2。一年就跌下不少，哪怕0.1分，也应该值得珍惜

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2143876, encodeId=bbe321438e667, content=审稿速度:12.0 | 投稿命中率:25.0<br>经验分享：7个多月后给出拒稿，基因家族在胃癌中的生信研究<br>sci分在不断往下走，真心不建议 试投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Tue Jun 20 13:36:38 CST 2023, time=2023-06-20, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1226110, encodeId=017f122611088, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享：迟迟不见状态改变啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83178200737, createdName=ms9000000393798485, createdTime=Mon Jun 13 08:59:36 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087225, encodeId=2d2a108e225fe, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087226, encodeId=5f43108e226b2, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575205, encodeId=bab65e520509, content=请问最后多久给消息了呀？是好消息还是坏消息？<span class="quote">lixindentist 2018-04-01 发表::<br>已经投稿1年多了，还是没有动静，这是怎么回事啊</span><span class="quote">lixindentist 2018-04-01 15:13:00 发表:<br>已经投稿1年多了，还是没有动静，这是怎么回事啊</span>, beContent=lixindentist 2018-04-01 发表:: 已经投稿1年多了，还是没有动静，这是怎么回事啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78212477466, createdName=才开始, createdTime=Thu Aug 22 00:00:00 CST 2019, time=2019-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554412, encodeId=cc305544124b, content=已经投稿1年多了，还是没有动静，这是怎么回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=afc01712357, createdName=lixindentist, createdTime=Sun Apr 01 15:13:00 CST 2018, time=2018-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539888, encodeId=a2bf5398883a, content=跌跌不休，再往下，会不会破2。一年就跌下不少，哪怕0.1分，也应该值得珍惜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13801938855, createdTime=Tue Jul 18 18:36:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537766, encodeId=5a1a53e766e4, content=一审到接收，1年半, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=367, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e49d1622204, createdName=xiaxianyue1912, createdTime=Wed Jun 14 07:54:00 CST 2017, time=2017-06-14, status=1, ipAttribution=)]
    2017-06-14 xiaxianyue1912

    一审到接收，1年半

    0

共12条页码: 1/2页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map